Related Experiment Video
Updated: Jan 2, 2026
07:19
Bioluminescent Optogenetics 2.0: Harnessing Bioluminescence to Activate Photosensory Proteins In Vitro and In Vivo
Published on: August 4, 2021
5.2K
A new bioluminescence-based tool for modulating target proteins in live cells
Tetsuya Ishimoto1, Hisashi Mori2
1Department of Molecular Neuroscience, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan. ishimoto@med.u-toyama.ac.jp.
Scientific Reports
|December 5, 2019
Summary
Researchers created a new tool to generate reactive oxygen species (ROS) at specific proteins in cells. This tool, KillerFirefly, induced Alzheimer's disease-associated actin rods, suggesting ROS controls actin regulation.
Area of Science:
- Biochemistry
- Cell Biology
- Neuroscience
Background:
- Reactive oxygen species (ROS) play crucial roles in cellular signaling.
- Actin dynamics are critical for cellular structure and function.
- Alzheimer's disease is associated with protein aggregation and cellular dysfunction.
Purpose of the Study:
- To develop a genetically encoded tool for targeted ROS generation in live cells.
- To investigate the role of low-level ROS in regulating F-actin structures.
- To explore potential links between ROS-induced actin changes and Alzheimer's disease pathology.
Main Methods:
- Development of a fusion protein (KillerFirefly) combining firefly luciferase and KillerRed photosensitizer.
- Targeting KillerFirefly to F-actin in cultured cells.
- Induction of ROS generation using luciferin and light.
Main Results:
- Targeted ROS generation by KillerFirefly induced cofilin-actin rods, a structure observed in Alzheimer's disease.
- Consistent, low-level ROS production near F-actin was sufficient to elicit this structural change.
- Evidence suggests an endogenous ROS-controlled system regulates actin.
Conclusions:
- The KillerFirefly tool enables precise, localized ROS generation for studying cellular processes.
- Low-level ROS can significantly impact F-actin organization, mimicking pathological changes.
- This study provides insights into ROS-mediated actin regulation and its potential relevance to neurodegenerative diseases like Alzheimer's.
